These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36779140)

  • 1. Herd Immunity to Fight Against COVID-19: A Narrative Review.
    Suryawanshi YN; Biswas DA
    Cureus; 2023 Jan; 15(1):e33575. PubMed ID: 36779140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
    Shelly A; Gupta P; Ahuja R; Srichandan S; Meena J; Majumdar T
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33050511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
    She J; Hou D; Chen C; Bi J; Song Y
    Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Africa achieve herd immunity?
    Lucero-Prisno DE; Ogunkola IO; Esu EB; Adebisi YA; Lin X; Li H
    Glob Health Res Policy; 2021 Dec; 6(1):46. PubMed ID: 34852844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in Engendering Herd Immunity to SARS-CoV-2 Infection: Possibly Impossible But Plausibile.
    Mukherjee S; Ray SK
    Infect Disord Drug Targets; 2022; 22(4):e170122200309. PubMed ID: 35040409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.
    Khoshkam Z; Aftabi Y; Stenvinkel P; Paige Lawrence B; Rezaei MH; Ichihara G; Fereidouni S
    J Adv Res; 2021 Jul; 31():49-60. PubMed ID: 33520309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Pandemic: A Compressive Review on Gender, Herd Immunity, and Physiological Mechanisms.
    Sisay T; Tolessa T
    Risk Manag Healthc Policy; 2020; 13():2963-2974. PubMed ID: 33363420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions.
    Khan WH; Hashmi Z; Goel A; Ahmad R; Gupta K; Khan N; Alam I; Ahmed F; Ansari MA
    Front Cell Infect Microbiol; 2021; 11():690621. PubMed ID: 34568087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herd Immunity Against Coronavirus: A Review.
    Datta S; Roy A
    Recent Pat Biotechnol; 2022 Aug; 16(3):256-265. PubMed ID: 35400332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US, Asia, Europe, Africa, South America, and the World.
    Cihan P
    Appl Soft Comput; 2021 Nov; 111():107708. PubMed ID: 34305491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity.
    Pacheco-García U; Serafín-López J
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines.
    Basheeruddin Asdaq SM; Jomah S; Rabbani SI; Alamri AM; Salem Alshammari SK; Duwaidi BS; Alshammari MS; Alamri AS; Alsanie WF; Alhomrani M; Sreeharsha N; Imran M
    Can J Infect Dis Med Microbiol; 2022; 2022():6913772. PubMed ID: 35186175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical interpretative synthesis of herd immunity for COVID-19 pandemic.
    Garg S; Singh MM; Deshmukh CP; Bhatnagar N; Borle AL; Kumar R
    J Family Med Prim Care; 2021 Mar; 10(3):1117-1123. PubMed ID: 34041138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylaxis and allergic reactions to COVID-19 vaccines: A narrative review of characteristics and potential obstacles on achieving herd immunity.
    Mahdiabadi S; Rezaei N
    Health Sci Rep; 2022 Sep; 5(5):e787. PubMed ID: 36032518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 herd immunity in the absence of a vaccine: an irresponsible approach.
    Khalife J; VanGennep D
    Epidemiol Health; 2021; 43():e2021012. PubMed ID: 33541010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.